FDA slaps U.S. Red Cross with $16 million in fines over blood safety violations

June 17, 2010 by MassDevice staff

The Food & Drug Administration fines the American Red Cross $16 million over the collection and manufacture of blood products.

FDA, USRC logos

The Food & Drug Administration fined the American Red Cross $16 million for failing to meet federal rules about the collection and manufacture of blood products.

The federal watchdog agency said it found no evidence of danger ton patients or of any compromise to the blood supply, despite the violations.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp